Neuro23 takes in $100m Series C
Neuron23 Inc., a developer of precision medicines, has secured $100 million in Series C financing.
Neuron23 Inc., a developer of precision medicines, has secured $100 million in Series C financing.
Copyright PEI Media
Not for publication, email or dissemination